HEALTH DISCOVERY CORPORATION: 10-Q filed 2012-11-16
What HEALTH DISCOVERY CORPORATION reported in its quarterly report filed 2012-11-16 (fiscal Q3 2012): 31 published measures, 81 facts as tagged in accession 0001188112-12-003437.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-11-16
- Fiscal period
- fiscal Q3 2012
- Accession
- 0001188112-12-003437 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HEALTH DISCOVERY CORPORATION filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 5,306,831 | USD | |
| At 2011-12-31 | 2,990,389 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 3,457,946 | USD | |
| At 2011-12-31 | 1,568,600 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,848,885 | USD | |
| At 2011-12-31 | 1,421,789 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 387,484 | USD | |
| At 2011-12-31 | 890,326 | USD | |
| At 2011-09-30 | 1,522,280 | USD | |
| At 2010-12-31 | 3,295,630 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,483,280 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 694,635 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -648,855 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -1,669,644 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 3,879 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 3,798 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -16,501 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | -24,882,282 | USD | |
| At 2011-12-31 | -25,576,917 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 232,457,588 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 231,907,958 | shares | 274 |
| 2011-07-01 to 2011-09-30 | 230,725,747 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 230,031,303 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 249,826,717 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 232,523,320 | shares | 274 |
| 2011-07-01 to 2011-09-30 | 230,725,747 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 230,031,303 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0.006 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | 0.001 | USD/shares | 274 |
| 2011-07-01 to 2011-09-30 | -0.003 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.007 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 0.006 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | 0.001 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 13,754 | USD | |
| At 2011-12-31 | 17,609 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 100,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 9,992 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,146,845 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -650,294 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -2,158,856 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 3,250,561 | USD | |
| At 2011-12-31 | 936,073 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,564,503 | USD | |
| At 2011-12-31 | 534,707 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 162,366 | USD | |
| At 2011-12-31 | 378,154 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,794,904 | USD | |
| At 2011-12-31 | 1,991,943 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 567 | USD | |
| At 2011-12-31 | 397 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 721,902 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,440,805 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 682,449 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 2,248,028 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 24,118 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 97,267 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 10,980 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 139,514 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 232,773,144 | shares | |
| At 2011-12-31 | 231,299,810 | shares |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 44,795 | USD | |
| At 2011-12-31 | 37,061 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 6,250 | USD | |
| At 2011-12-31 | 21,500 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 45,350 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,448,315 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 240,237 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -684,198 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -1,778,659 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 204,774 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 204,182 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 65,680 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 197,040 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 65,680 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 197,040 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,473,288 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 1,841,480 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 1,439 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 489,212 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 170 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -334,710 | USD | 273 |
Inspect the source
- Entity
- HEALTH DISCOVERY CORPORATION / CIK 0001141788
- Captured
- SEC response SHA-256
0d6fed061cdbc8ee974d84a3c55093843e6d411f7efb969a0fb9254c76a2e9fa
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001141788.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))